Clinical Trial

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Study acronym: GOTIM
Recruiting
View on ClinicalTrials.gov →
Summary
This trial is a prospective, monocentric, non-therapeutic, interventional cohort study aiming to decipher the immune TME through standard neoadjuvant CT in resectable G/GEJ adenocarcinomas. This study will also longitudinally monitor MRD during neoadjuvant and adjuvant therapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-01; most recent amendment 2023-08-29.
Status change: Not Yet Recruiting → Recruiting 2023-08-29
Trial Details
NCT Number NCT05644431
Lead Sponsor Centre Leon Berard
Conditions GastroEsophageal Cancer
Enrollment 50 participants
Start Date 2023-07-19
Primary Completion 2028-01-15 (estimated)
Study Completion 2028-01-15 (estimated)
Updated on ClinicalTrials.gov 2023-08-30